Tag: Heart / Stroke-Related: Coronary-Artery Disease
Stratification Tool IDs Who Will Benefit From Adding Ezetimibe
Tool identifies who will derive additional benefit from addition of ezetimibe to statin therapy after ACS
PCI Viable Alternative to CABG for Left Main Coronary Artery Disease
PCI is safe, efficacious in appropriately selected patients; randomized studies will aid decision making
High TG, Low HDL-C Levels May Help Further Stratify CHD Risk
Fasting high TG + low HDL associated with increased risk, particularly in those with diabetes
Dual Antiplatelet Tx Similar to Aspirin Post-CABG in Diabetes
No differences in cardiovascular, bleeding outcomes in patients with diabetes receiving DAPT, aspirin
Noncardiovascular Cause of Death More Common in CHD Patients
Predictors of noncardiac death include older age, inducible ischemia, higher heart rate, statin nonuse
High-Intensity Statins Tied to Better Survival in CVD Patients
Significant survival advantage compared with moderate-intensity statins, even among older adults
Depressive Symptoms Linked to Functional Status in CAD
Patients with class II, III, or IV functional status have increased risk of hospitalization for heart failure
PCI Noninferior to CABG for Left Main Coronary Artery Disease
PCI with everolimus-eluting stent noninferior for composite of death, stroke, or MI at three years
Liraglutide Increases Heart Rate in T2DM With Stable CAD
Reduction in heart rate variability despite weight loss and improvement in metabolic parameters
Five-Year Outcomes Similar for Off-, On-Pump CABG in CAD
No significant difference for composite outcome, components of the composite outcome, mean cost
